Annual Cash & Cash Equivalents
$19.16 M
+$4.04 M+26.70%
December 31, 2024
Summary
- As of February 7, 2025, CLB annual cash & cash equivalents is $19.16 million, with the most recent change of +$4.04 million (+26.70%) on December 31, 2024.
- During the last 3 years, CLB annual cash & cash equivalents has risen by +$1.45 million (+8.21%).
- CLB annual cash & cash equivalents is now -89.42% below its all-time high of $181.04 million, reached on December 31, 2009.
Performance
CLB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.16 M
-$2.32 M-10.79%
December 31, 2024
Summary
- As of February 7, 2025, CLB quarterly cash and cash equivalents is $19.16 million, with the most recent change of -$2.32 million (-10.79%) on December 31, 2024.
- Over the past year, CLB quarterly cash and cash equivalents has increased by +$4.04 million (+26.70%).
- CLB quarterly cash and cash equivalents is now -89.42% below its all-time high of $181.04 million, reached on December 31, 2009.
Performance
CLB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.7% | +26.7% |
| 3 y3 years | +8.2% | +26.7% |
| 5 y5 years | +72.7% | +26.7% |
CLB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.7% | -26.9% | +39.5% |
| 5 y | 5-year | at high | +72.7% | -43.0% | +72.7% |
| alltime | all time | -89.4% | +560.6% | -89.4% | +1177.1% |
Core Laboratories NV Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $19.16 M(+26.7%) | $19.16 M(-10.8%) |
| Sep 2024 | - | $21.47 M(+21.4%) |
| Jun 2024 | - | $17.70 M(+18.7%) |
| Mar 2024 | - | $14.91 M(-1.4%) |
| Dec 2023 | $15.12 M(-2.0%) | $15.12 M(-9.0%) |
| Sep 2023 | - | $16.62 M(-36.6%) |
| Jun 2023 | - | $26.20 M(+60.9%) |
| Mar 2023 | - | $16.29 M(+5.6%) |
| Dec 2022 | $15.43 M(-12.9%) | $15.43 M(+12.4%) |
| Sep 2022 | - | $13.73 M(-15.0%) |
| Jun 2022 | - | $16.15 M(-26.7%) |
| Mar 2022 | - | $22.04 M(+24.5%) |
| Dec 2021 | $17.70 M(+28.2%) | $17.70 M(-7.1%) |
| Sep 2021 | - | $19.05 M(-43.3%) |
| Jun 2021 | - | $33.62 M(+20.9%) |
| Mar 2021 | - | $27.81 M(+101.4%) |
| Dec 2020 | $13.81 M(+24.5%) | $13.81 M(-8.8%) |
| Sep 2020 | - | $15.15 M(-27.7%) |
| Jun 2020 | - | $20.96 M(+50.9%) |
| Mar 2020 | - | $13.89 M(+25.2%) |
| Dec 2019 | $11.09 M(-15.4%) | $11.09 M(-15.5%) |
| Sep 2019 | - | $13.13 M(+4.6%) |
| Jun 2019 | - | $12.55 M(-5.0%) |
| Mar 2019 | - | $13.21 M(+0.7%) |
| Dec 2018 | $13.12 M(-8.9%) | $13.12 M(-7.0%) |
| Sep 2018 | - | $14.10 M(+8.3%) |
| Jun 2018 | - | $13.02 M(-1.7%) |
| Mar 2018 | - | $13.24 M(-8.0%) |
| Dec 2017 | $14.40 M(-2.5%) | $14.40 M(+4.5%) |
| Sep 2017 | - | $13.78 M(-3.8%) |
| Jun 2017 | - | $14.32 M(-0.2%) |
| Mar 2017 | - | $14.34 M(-2.9%) |
| Dec 2016 | $14.76 M(-34.4%) | $14.76 M(-14.3%) |
| Sep 2016 | - | $17.22 M(+16.5%) |
| Jun 2016 | - | $14.78 M(-11.3%) |
| Mar 2016 | - | $16.66 M(-25.9%) |
| Dec 2015 | $22.49 M(-3.7%) | $22.49 M(+21.8%) |
| Sep 2015 | - | $18.46 M(-18.2%) |
| Jun 2015 | - | $22.58 M(+18.0%) |
| Mar 2015 | - | $19.14 M(-18.0%) |
| Dec 2014 | $23.35 M(-6.9%) | $23.35 M(-7.7%) |
| Sep 2014 | - | $25.31 M(-14.4%) |
| Jun 2014 | - | $29.55 M(+27.1%) |
| Mar 2014 | - | $23.25 M(-7.3%) |
| Dec 2013 | $25.09 M(+30.5%) | $25.09 M(+13.0%) |
| Sep 2013 | - | $22.20 M(-4.4%) |
| Jun 2013 | - | $23.22 M(+1.3%) |
| Mar 2013 | - | $22.93 M(+19.2%) |
| Dec 2012 | $19.23 M(-34.5%) | $19.23 M(-22.0%) |
| Sep 2012 | - | $24.66 M(+5.3%) |
| Jun 2012 | - | $23.41 M(-0.5%) |
| Mar 2012 | - | $23.54 M(-19.8%) |
| Dec 2011 | $29.33 M(-78.1%) | $29.33 M(+72.3%) |
| Sep 2011 | - | $17.02 M(-30.7%) |
| Jun 2011 | - | $24.56 M(-69.3%) |
| Mar 2011 | - | $80.01 M(-40.2%) |
| Dec 2010 | $133.88 M | $133.88 M(-20.3%) |
| Sep 2010 | - | $167.95 M(-3.3%) |
| Jun 2010 | - | $173.62 M(+25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $138.77 M(-23.4%) |
| Dec 2009 | $181.04 M(+401.0%) | $181.04 M(+31.9%) |
| Sep 2009 | - | $137.22 M(+32.9%) |
| Jun 2009 | - | $103.25 M(+41.4%) |
| Mar 2009 | - | $73.04 M(+102.1%) |
| Dec 2008 | $36.14 M(+41.1%) | $36.14 M(-38.0%) |
| Sep 2008 | - | $58.27 M(+6.7%) |
| Jun 2008 | - | $54.63 M(+91.5%) |
| Mar 2008 | - | $28.53 M(+11.4%) |
| Dec 2007 | $25.62 M(-52.8%) | $25.62 M(-39.3%) |
| Sep 2007 | - | $42.17 M(-22.5%) |
| Jun 2007 | - | $54.38 M(+87.6%) |
| Mar 2007 | - | $28.99 M(-46.5%) |
| Dec 2006 | $54.22 M(+294.5%) | $54.22 M(+335.3%) |
| Sep 2006 | - | $12.46 M(+2.5%) |
| Jun 2006 | - | $12.15 M(-24.2%) |
| Mar 2006 | - | $16.03 M(+16.6%) |
| Dec 2005 | $13.74 M(-14.3%) | $13.74 M(-28.1%) |
| Sep 2005 | - | $19.11 M(+0.9%) |
| Jun 2005 | - | $18.93 M(+6.3%) |
| Mar 2005 | - | $17.81 M(+11.1%) |
| Dec 2004 | $16.03 M(-1.2%) | $16.03 M(-9.4%) |
| Sep 2004 | - | $17.69 M(-10.0%) |
| Jun 2004 | - | $19.66 M(+35.2%) |
| Mar 2004 | - | $14.54 M(-10.4%) |
| Dec 2003 | $16.23 M(+9.1%) | $16.23 M(+1.9%) |
| Sep 2003 | - | $15.93 M(+9.4%) |
| Jun 2003 | - | $14.56 M(+37.1%) |
| Mar 2003 | - | $10.62 M(-28.6%) |
| Dec 2002 | $14.88 M(+2.9%) | $14.88 M(+2.0%) |
| Sep 2002 | - | $14.58 M(-16.8%) |
| Jun 2002 | - | $17.54 M(+13.4%) |
| Mar 2002 | - | $15.47 M(+7.0%) |
| Dec 2001 | $14.46 M(+15.5%) | $14.46 M(+8.6%) |
| Sep 2001 | - | $13.31 M(-12.2%) |
| Jun 2001 | - | $15.16 M(+11.6%) |
| Mar 2001 | - | $13.59 M(+8.5%) |
| Dec 2000 | $12.52 M(-34.1%) | $12.52 M(-9.5%) |
| Sep 2000 | - | $13.83 M(-23.4%) |
| Jun 2000 | - | $18.05 M(+34.3%) |
| Mar 2000 | - | $13.44 M(-29.2%) |
| Dec 1999 | $18.98 M(+131.5%) | $18.98 M(+9.7%) |
| Sep 1999 | - | $17.30 M(+58.7%) |
| Jun 1999 | - | $10.90 M(+60.3%) |
| Mar 1999 | - | $6.80 M(-17.1%) |
| Dec 1998 | $8.20 M(-35.4%) | $8.20 M(-45.0%) |
| Sep 1998 | - | $14.90 M(+86.3%) |
| Jun 1998 | - | $8.00 M(+122.2%) |
| Mar 1998 | - | $3.60 M(-71.7%) |
| Dec 1997 | $12.70 M(+337.9%) | $12.70 M(+44.3%) |
| Sep 1997 | - | $8.80 M(+166.7%) |
| Jun 1997 | - | $3.30 M(+73.7%) |
| Mar 1997 | - | $1.90 M(-34.5%) |
| Dec 1996 | $2.90 M(-32.6%) | $2.90 M(+93.3%) |
| Sep 1996 | - | $1.50 M(-51.6%) |
| Jun 1996 | - | $3.10 M(+14.8%) |
| Mar 1996 | - | $2.70 M(-37.2%) |
| Dec 1995 | $4.30 M | $4.30 M(+95.5%) |
| Sep 1995 | - | $2.20 M |
FAQ
- What is Core Laboratories NV annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Core Laboratories NV?
- What is Core Laboratories NV annual cash & cash equivalents year-on-year change?
- What is Core Laboratories NV quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Core Laboratories NV?
- What is Core Laboratories NV quarterly cash and cash equivalents year-on-year change?
What is Core Laboratories NV annual cash & cash equivalents?
The current annual cash & cash equivalents of CLB is $19.16 M
What is the all time high annual cash & cash equivalents for Core Laboratories NV?
Core Laboratories NV all-time high annual cash & cash equivalents is $181.04 M
What is Core Laboratories NV annual cash & cash equivalents year-on-year change?
Over the past year, CLB annual cash & cash equivalents has changed by +$4.04 M (+26.70%)
What is Core Laboratories NV quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLB is $19.16 M
What is the all time high quarterly cash and cash equivalents for Core Laboratories NV?
Core Laboratories NV all-time high quarterly cash and cash equivalents is $181.04 M
What is Core Laboratories NV quarterly cash and cash equivalents year-on-year change?
Over the past year, CLB quarterly cash and cash equivalents has changed by +$4.04 M (+26.70%)